Brief: Hemab Therapeutics Prices Upsized IPO Of 16,750,000 Shares At $18.00 Per Share
April 30 (Reuters) - Hemab Therapeutics Holdings Inc COAG.O: HEMAB THERAPEUTICS ANNOUNCES PRICING OF UPSIZED INITIAL PUBLIC OFFERING HEMAB THERAPEUTICS HOLDINGS INC - PRICES IPO OF 16,750,000 SHARES AT $18.00 PER SHARE Source text: ID:nGNX8c5rGY Further company coverage: COAG.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hemab Therapeutics Holdings
See all newsUS RESEARCH ROUNDUP-BlackRock, Microsoft, TransDigm Group
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage
Brief: Hemab Therapeutics Reports Second Quarter 2026 Financial Results And Provides Corporate Update
Biotech firm Odyssey raises $279 million in upsized US IPO (updated)
NASDAQ RESUMED AT 12:30 PM